Key Highlights
- As part of routine regulatory surveillance, the Central Drugs Standard Control Organisation (CDSCO) uploads a consolidated list of Not of Standard Quality (NSQ) and spurious drugs on its portal every month, reported PTI.
- “For the month of December 2025, Central Drugs Laboratories have identified 74 Drug Samples to be Not of Standard Quality (NSQ) and State Drugs Testing Laboratories have identified 93 samples as Not of Standard Quality (NSQ),” the statement said.
- ADVERTISEMENT The ministry clarified that a drug sample is classified as NSQ when it fails to meet one or more specified quality parameters.
- Such failure is limited to the specific batch tested by the government laboratory and does not raise concerns about other batches or drug products available in the market.
- Further, during December 2025, four drug samples from the North Zone (Ghaziabad) and one sample each from FDA Ahmedabad, Bihar, and Maharashtra were identified as spurious.
